“Lyophilization in Pharmaceuticals market set to grow to $9.2bn by 2024” says new Visiongain report

28 March 2019
Pharma

Visiongain has published a new pharma report Lyophilization in Pharmaceuticals Market Forecast 2019-2029: Food Processing and Packaging, Pharmaceutical and Biotechnology, Medical Application, Industrial-scale, Pilot-scale, Laboratory-scale, Tray-style Freeze Dryers, Manifold Freeze Dryers, Shell Freeze Dryers, Loading & Unloading Systems, Controlling & Monitoring Systems, Vacuum Systems, Clean-In-Place (CIP) Systems, Drying Chambers, Freeze Drying Trays & Shelves, Manifolds, Other Accessories.

The global lyophilization in pharmaceuticals market is estimated to have reached $5.6bn in 2018. The pharmaceutical and biotechnology segment held 33% of the lyophilization market in 2018.

Pharmaceutical and biotechnology drugs are often highly sensitive and complex molecules that can be negatively affected by external factors such as sunlight, oxygen, pH and others. Leaving marketers and manufacturers looking for an innovative way to preserve and protect these difficult-to-handle substances, lyophilization offers a highly efficient and suitable technique to meet the needs for handling the complexities of constituents during pharmaceutical manufacturing.

The lead analyst commented that "Lyophilization in pharmaceuticals and biotechnology is growing at a rapid pace due to the high safety and sterility offered by freeze-dried injectables, mainly in the case of unstable proteins that are highly susceptible to chemical and physical disintegration and changes.

The lyophilization market includes a large number of small and medium-sized companies and stable innovative activity. End-users have the opportunity to choose from a number of suppliers. External forces have a significant effect on this industry, such as government involvement regulatory agencies and reimbursement policies. On a global level, we can expect growth in this market, especially in the emerging economies."

Leading companies featured in this report include Azbil Corporation, Biophama process Systems, Inc., GEA Group, Labconco Corporation, Millrock Technology, Inc.and others.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever